- 收听数
- 0
- 性别
- 保密
- 听众数
- 3
- 最后登录
- 2016-2-1
- QQ
- UID
- 5746
- 阅读权限
- 20
- 帖子
- 565
- 精华
- 0
- 在线时间
- 121 小时
- 注册时间
- 2013-8-26
- 科研币
- 5
- 速递币
- 26
- 娱乐币
- 432
- 文献值
- 0
- 资源值
- 0
- 贡献值
- 0
|
5速递币
题名 | Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: retrospective analysis of patient data from five clinical trials. | 链接 | http://www.ncbi.nlm.nih.gov/pubmed/26687797 |
|
|